Filing Details

Accession Number:
0001225208-13-023274
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-12 16:51:11
Reporting Period:
2013-11-08
Filing Date:
2013-11-12
Accepted Time:
2013-11-12 16:51:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885725 Boston Scientific Corp BSX Surgical & Medical Instruments & Apparatus (3841) 042695240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1566094 B. Jeffrey Mirviss One Boston Scientific Place
Natick MA 01760-1537
Svp&Pres, Periph Intervent No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-11-08 20,000 $11.87 45,190 No 4 S Direct
Common Stock Disposition 2013-11-11 6,000 $12.02 39,190 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,645 Indirect By 401(k)
Footnotes
  1. Represents the weighted average sale price. These shares were sold in multiple transactions at $11.8700 and $11.8710. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  2. Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
  3. Represents the weighted average sale price. These shares were sold in multiple transactions at $12.0202 and $12.0220. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.